Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | PTGES | O14684 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | RARA | P10276 | 2/20 | 0.33 |
| ▸ | RARB | P10826 | 2/20 | 0.33 |
| ▸ | RARG | P13631 | 2/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | HRH1 | P35367 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21361741 | 0.78 | MAPT (0.34) | MEN1KMT2APOLBMAPTPKM | |
| SCHEMBL13684330 | 0.78 | KDM4E (0.48) | KMT2ARARARARBRARGHTR1A | |
| SCHEMBL11912105 | 0.76 | RARA (0.40) | MEN1KMT2AALDH1A1RARARARB | |
| SCHEMBL12308312 | 0.75 | SMN1; SMN2 (0.43) | HTR1ADRD2 | |
| SCHEMBL10299246 | 0.75 | HTR1A (0.40) | ALDH1A1HTR1ADRD2HPGDNPSR1 | |
| SCHEMBL1514142 | 0.73 | MEN1 (0.38) | MEN1KMT2APOLBPTGESALOX5 | |
| SCHEMBL13199770 | 0.73 | RARA (0.31) | RARARARBRARG | |
| SCHEMBL6956406 | 0.73 | — | — | |
| SCHEMBL1698550 | 0.73 | SMN1; SMN2 (0.41) | MEN1KMT2AMAPTPKMALDH1A1 | |
| SCHEMBL16472357 | 0.71 | MAPT (0.34) | MEN1KMT2APOLBMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10840397-B2 | Highly-fluorescent and photo-stable chromophores for wavelength conversion | NITTO DENKO CORPORATION (JP) | 2020-11-17 | — | — | US | disclosed |
| US-20190284471-A1 | WAVELENGTH CONVERSION FILMS WITH MULTIPLE PHOTOSTABLE ORGANIC CHROMOPHORES | CHOSHU INDUSTRY CO., LTD. (JP) | 2019-09-19 | — | — | US | disclosed |
| US-20180193330-A1 | ALKYLATED TETRAHYDROISOQUINOLINES FOR BINDING TO CENTRAL NERVOUS SYSTEM RECEPTORS | FLORIDA A&M UNIVERSITY | 2018-07-12 | — | — | US | disclosed |
| US-20180193330-A1 | ALKYLATED TETRAHYDROISOQUINOLINES FOR BINDING TO CENTRAL NERVOUS SYSTEM RECEPTORS | FLORIDA A&M UNIVERSITY | 2018-07-12 | — | — | US | disclosed |
| US-9960294-B2 | Highly fluorescent and photo-stable chromophores for wavelength conversion | NITTO DENKO CORPORATION (JP) | 2018-05-01 | — | — | US | disclosed |
| US-9960294-B2 | Highly fluorescent and photo-stable chromophores for wavelength conversion | NITTO DENKO CORPORATION (JP) | 2018-05-01 | — | — | US | disclosed |
| EP-2941474-B1 | HIGHLY-FLUORESCENT AND PHOTO-STABLE CHROMOPHORES FOR WAVELENGTH CONVERSION | NITTO DENKO CORP (JP) | 2018-02-28 | — | — | EP | disclosed |
| US-20160108310-A1 | WAVELENGTH CONVERSION FILMS WITH MULTIPLE PHOTOSTABLE ORGANIC CHROMOPHORES | NITTO DENKO CORPORATION (JP) | 2016-04-21 | — | — | US | disclosed |
| US-9221765-B2 | Inhibition and dispersion of bacterial biofilms with benzimidazole derivatives | NORTH CAROLINA STATE UNIVERSITY (US) | 2015-12-29 | — | — | US | disclosed |
| US-20150340519-A1 | HIGHLY-FLUORESCENT AND PHOTO-STABLE CHROMOPHORES FOR WAVELENGTH CONVERSION | NITTO DENKO CORPORATION (JP) | 2015-11-26 | — | — | US | disclosed |
| US-20120171129-A1 | Inhibition and Dispersion of Bacterial Biofilms with Benzimidazole Derivatives | NORTH CAROLINA STATE UNIVERSITY | 2012-07-05 | — | — | US | disclosed |
| US-7592419-B2 | Macrocyclic inhibitors of hepatitis C virus NS3-serine protease | SCHERING CORPORATION (US) | 2009-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180193330-A1 | ALKYLATED TETRAHYDROISOQUINOLINES FOR BINDING TO CENTRAL NERVOUS SYSTEM RECEPTORS | NTSR2, HTR3B, NTSR1 | MEN1 1725/4885KMT2A 2709/4885POLB 4776/4885 |
| US-20120171129-A1 | Inhibition and Dispersion of Bacterial Biofilms with Benzimidazole Derivatives | SBDS, DBI, BRI3BP | MEN1 4397/4885KMT2A 2548/4885POLB 462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.